HIV HGP-30W vaccine - CEL-SCI

Drug Profile

HIV HGP-30W vaccine - CEL-SCI

Alternative Names: HGP-30; HGP-30W; HIV p17 vaccine

Latest Information Update: 28 Sep 2006

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator CEL-SCI Corporation
  • Developer AIDS Research Alliance; University of Nebraska Medical Center
  • Class AIDS vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 28 Sep 2006 Discontinued - Phase-I for HIV infections treatment in United Kingdom (Injection)
  • 28 Sep 2006 Discontinued - Phase-II for HIV infections treatment in Netherlands (Injection)
  • 28 Sep 2006 Discontinued - Phase-II for HIV infections treatment in USA (Injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top